Upon the aggregation, tau is known to serve neurodegenerative functions in the pathological conditions, including AD, Pick disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and frontotemporal dementia with parkinsonism-17 (FTDP-17) [108]. This evidence concerns the gene MAPT and Alzheimer disease.